Soluble intercellular adhesion molecule 1 in spondylarthropathies

Area of Science:

• Immunology
• Rheumatology
• Biochemistry

Background:

• Intercellular adhesion molecule 1 (ICAM-1) plays a role in immune cell adhesion.
• The soluble form, sICAM-1, is a potential biomarker for inflammatory conditions.
• Spondylarthropathies (SpA) are a group of inflammatory joint diseases.

Purpose of the Study:

• To assess serum sICAM-1 levels in patients with spondylarthropathies (SpA).
• To investigate the correlation between sICAM-1 and key inflammatory markers in SpA.
• To compare sICAM-1 levels in SpA patients with healthy controls and rheumatoid arthritis (RA) patients.

Main Methods:

• Serum samples were collected from 25 SpA patients, 20 healthy controls, and 20 RA patients.
• Soluble intercellular adhesion molecule 1 (sICAM-1) levels were quantified using enzyme-linked immunosorbent assay (ELISA).
• Correlations were analyzed between sICAM-1 levels and inflammatory parameters including erythrocyte sedimentation rate, C-reactive protein, interleukin-6, tumor necrosis factor alpha, and IgA.

Main Results:

• Serum sICAM-1 levels were found to be elevated in SpA patients compared to controls, though not significantly.
• A notable percentage (28%) of SpA patients exhibited high sICAM-1 levels (> 400 ng/ml), a finding not observed in RA or control groups.
• Significant correlations were identified between sICAM-1 and erythrocyte sedimentation rate, C-reactive protein, and interleukin-6 in SpA patients.
• These correlations were absent in patients with rheumatoid arthritis (RA).

Conclusions:

• Serum sICAM-1 levels may serve as an indicator of the acute phase of inflammation in spondylarthropathies (SpA).
• The distinct elevation and correlation patterns of sICAM-1 in SpA suggest its specific involvement in the inflammatory process of these conditions.
• Further research into sICAM-1 as a biomarker for SpA activity is warranted.